Bio-boosted Beauty

In the multi-billion dollar skin care world awash with hyped “anti-aging miracle” claims, a groundbreaking new company is cutting through the airbrushed fantasies. Agenek,   launched by York alumnae and molecular biologists Anna Kotova (BSc ’16,  PhD ’22) and Ksenia Timonina (PhD ’22), takes personalized skin care to an unprecedented level by analyzing individuals’ genes to understand how unique biology impacts skin aging and health.

“Drawing from our backgrounds in molecular biology and genetics, we’ve always been passionate about leveraging these tools to explore our biological makeup,” Kotova explains. Their proprietary process examines facial skin cells and gene data to identify each client’s unique “problem genes,” then recommends existing product formulations scientifically proven to treat those specific issues.

“We recognized the potential of transcriptomic analysis for personalized skin care solutions,” she explains. The co-founders met during graduate studies at York, where they acquired techniques enabling this innovative approach.  

While a fledgling startup,  Agenek is tapping into an explosive market – global skin care sales are projected to top $185 billion by 2027, as demand for customization soars. Their company, supported by York’s entrepreneurship ecosystem, including the female-centric ELLA program within YSpace, is rapidly gaining momentum.

“At Agenek, we’re committed to using the latest molecular advancements,” Kotova says. “Our RNA-based testing provides unprecedented insights into gene expression and skin health.” For consumers bombarded by overhyped “miracle” product claims, it offers a science-driven alternative.

“We hope to empower individuals to understand their skin’s real biological needs and make informed choices, while advancing skin care innovation through cutting-edge technology.” ■